Skip to main content

CORRECTION article

Front. Oncol., 22 September 2022
Sec. Cancer Molecular Targets and Therapeutics

Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells

Hongqing Zhou Hongqing Zhou 1Mingsheng Liu Mingsheng Liu 1*Tao Shao Tao Shao 1Pingbo Xie Pingbo Xie 1Shaojie Zhu Shaojie Zhu 1Wei Wang Wei Wang 1Qiong Miao Qiong Miao 1Jiaxi Peng Jiaxi Peng 1Peng Zhang Peng Zhang 2*
  • 1 The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, China
  • 2 Department of Urology, Chinese People’s Liberation Army (PLA) General Hospital/Chinese PLA Medical Academy, China

A Corrigendum on
TPX2 enhanced the Activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-Independent prostate carcinoma cells

by Zhou Q, Liu M, Shao T, Xie P, Zhu S, Wang W, Miao Q, Peng J and Zhang P (2021) 11:618540. doi: 10.3389/fonc.2021.618540

An author name was incorrectly spelled as Qinghong Zhou. The correct spelling is Hongqing Zhou.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: the targeting protein for Xklp2, prostate carcinoma, E26 transformation specific sequence 1, metastasis, endocrine-independent

Citation: Zhou H, Liu M, Shao T, Xie P, Zhu S, Wang W, Miao Q, Peng J and Zhang P (2022) Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells. Front. Oncol. 12:1032265. doi: 10.3389/fonc.2022.1032265

Received: 30 August 2022; Accepted: 31 August 2022;
Published: 22 September 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhou, Liu, Shao, Xie, Zhu, Wang, Miao, Peng and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mingsheng Liu, 18908741981@189.cn; Peng Zhang, alwaysjumper@126.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.